Amneal Pharmaceuticals Inc (FRA:2DT)
€ 7.7 0 (0%) Market Cap: 2.45 Bil Enterprise Value: 4.93 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 62/100

Q3 2022 Amneal Pharmaceuticals Inc Earnings Call Transcript

Nov 04, 2022 / 12:30PM GMT
Release Date Price: €2.12 (-0.93%)
Operator

Hello, everyone, and welcome to the Amneal third quarter 2022 conference call. My name is Emily, and I will be your operator today. (Operator Instructions)

I will now turn the call over to [Maria Lacuri], Amneal Investor Relations. Please go ahead.

Unidentified Company Representative

Good morning, and thank you for joining Amneal's Third Quarter 2022 Earnings Call. Today, we issued a press release reporting our financial results. The press release and presentation are available at amneal.com, and a replay of this call will be posted after the call. Certain statements made on this call regarding matters that are not historical facts, including, but not limited, to management's outlook or predictions are forward-looking statements that are based solely on information that is now available to us. Please review the section entitled Cautionary Statements on Forward-Looking Statements in the earnings presentation and on our SEC filings for a discussion of factors that may impact our future performance.

We also discuss non-GAAP measures. Important

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot